TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-06
DOI
10.1038/s41388-018-0417-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
- (2017) David B. Nelson et al. JOURNAL OF CLINICAL ONCOLOGY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Inflammation-Related IL1 /IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma
- (2016) Y. Kadariya et al. Cancer Prevention Research
- Modeling mesothelioma utilizing human mesothelial cells reveals involvement of phospholipase-C beta 4 in YAP-active mesothelioma cell proliferation
- (2016) Tatsuo Kakiuchi et al. CARCINOGENESIS
- Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma
- (2016) Robin Tranchant et al. CLINICAL CANCER RESEARCH
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- YAP and TAZ: a nexus for Hippo signaling and beyond
- (2015) Carsten Gram Hansen et al. TRENDS IN CELL BIOLOGY
- Screening with a Novel Cell-Based Assay for TAZ Activators Identifies a Compound That Enhances Myogenesis in C2C12 Cells and Facilitates Muscle Repair in a Muscle Injury Model
- (2014) Z. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- The Global Spread of Asbestos
- (2014) Arthur L. Frank et al. Annals of Global Health
- Molecular pathogenesis of malignant mesothelioma
- (2013) Y. Sekido CARCINOGENESIS
- LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade
- (2013) I Tanaka et al. ONCOGENE
- Interleukin 24: Mechanisms and therapeutic potential of an anti-cancer gene
- (2012) Erin L. Whitaker et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition
- (2012) Wei Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
- (2012) Makiko Fujii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
- (2012) T Mizuno et al. ONCOGENE
- LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
- (2011) H. Murakami et al. CANCER RESEARCH
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
- (2011) K. P. L. Bhat et al. GENES & DEVELOPMENT
- TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
- (2009) Siew Wee Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
- (2008) S. W. Chan et al. CANCER RESEARCH
- YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation
- (2008) Toshihiko Yokoyama et al. CARCINOGENESIS
- TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal
- (2008) Xaralabos Varelas et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now